Blood Plasma Fractionation Facility

The Oasis project is a biotechnology complex for the Korean multinational Green Cross Biotherapeutics including an administrative headquarters.

A blood plasma-derived products warehouse and production plant dedicated to the production of albumin and immunoglobulin for the Canadian, American, and Chinese markets.

The Green Cross plant will have the capacity to process one million liters of plasma per year. This plant will contain all of the process equipment, clean rooms, laboratories and warehouse necessary for Green Cross's operations in Canada.

Fractionation operations use state-of-the-art biotechnology facilities. The head office features a branded multifunctional entrance and lobby, bright and modern office spaces, a cafeteria and changing rooms.